VPC
DNTH icon

Vestal Point Capital’s Dianthus Therapeutics DNTH Stock Holding History

Vestal Point Capital’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,180,000
Closed -$46.4M – 90
2025
Q3 		$46.4M Sell
1,180,000
-2,020,000
-63% -$51.6M 2.1% 15
2025
Q2 		$59.6M Buy
3,200,000
+1,499,931
+88% +$28.1M 3.14% 8
2025
Q1 		$30.8M Buy
1,700,069
+625,069
+58% +$13.8M 2.2% 16
2024
Q4 		$23.4M Buy
1,075,000
+680,000
+172% +$17.5M 1.39% 27
2024
Q3 		$10.8M Sell
395,000
-205,000
-34% -$5.71M 0.82% 31
2024
Q2 		$15.5M Buy
600,000
+145,000
+32% +$3.49M 1.16% 28
2024
Q1 		$13.7M Buy
455,000
+320,000
+237% +$6.96M 1.13% 23
2023
Q4 		$1.4M Buy
+135,000
New +$1.49M 0.15% 38

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return